VANDA PHARMACEUTICALS INC. (VNDA) Operating cash flow 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$109.4MFY2025 · since FY2016: -$8.1M → -$109.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$109.4M | -594.6% |
| FY2024 | -$15.8M | -223.1% |
| FY2023 | $12.8M | -60.0% |
| FY2022 | $32.0M | -50.2% |
| FY2021 | $64.2M | +24.0% |
| FY2020 | $51.8M | +12.7% |
| FY2019 | $45.9M | +53.2% |
| FY2018 | $30.0M | +1612.2% |
| FY2017 | -$2.0M | +75.5% |
| FY2016 | -$8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VNDA financial trends
VNDA RevenueVNDA Net incomeVNDA Net marginVNDA Gross profitVNDA Gross marginVNDA Operating incomeVNDA Operating marginVNDA Free cash flowVNDA Capital expendituresVNDA Return on equityVNDA Stock buybacksVNDA Dividends paidVNDA Total assetsVNDA Total liabilitiesVNDA Shareholders’ equityVNDA overview →